Analyst Ratings for Candel Therapeutics Inc. (CADL)
CADL Rating Summary
CADL Price Target Summary
- Highest: $23.00 (H.C. Wainwright)
- Lowest: $14.00 (Freedom Capital)
- Average: $17.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$17.57 (+114.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/21/2026 | BofA Securities | Alec Stranahan | Upgrade | Buy (Neutral) |
18.00 (12.00) |
10.85 (8.19) |
-24.52% | Details |
| 7/13/2026 | Stifel | Stephen Willey | New Coverage | Buy (N/A) |
22.00 (N/A) |
9.89 (8.19) |
-17.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
